Fractalkine/CX(3)CR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?

por Jeyalan, Visvesh, Austin, David, Loh, Shu Xian, Wangsaputra, Vincent Kharisma, Spyridopoulos, Ioakim
Publicado 2023

Reduction or de-escalation of dual antiplatelet therapy intensity or duration in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A mini-review

por Farag, Mohamed, Jeyalan, Visvesh, Ferreiro, Jose Luis, Jeong, Young-Hoon, Geisler, Tobias, Gorog, Diana A.
Publicado 2022

Fractalkine Signalling (CX(3)CL1/CX(3)CR1 Axis) as an Emerging Target in Coronary Artery Disease

por Loh, Shu Xian, Ekinci, Yasemin, Spray, Luke, Jeyalan, Visvesh, Olin, Thomas, Richardson, Gavin, Austin, David, Alkhalil, Mohammad, Spyridopoulos, Ioakim
Publicado 2023